Joshua Boger

3.1k total citations · 2 hit papers
40 papers, 2.5k citations indexed

About

Joshua Boger is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joshua Boger has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joshua Boger's work include Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (6 papers). Joshua Boger is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (6 papers). Joshua Boger collaborates with scholars based in United States, United Kingdom and Indonesia. Joshua Boger's co-authors include Debra S. Perlow, Emilio A. Emini, Jean‐Maríe Lehn, Richard J. Corcoran, Edward H. Blaine, Terry W. Schorn, Linda S. Payne, Jeremy R. Knowles, Bruce I. LaMont and Martin Poe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Joshua Boger

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

1985 991 citations Debra S. Perlow, Joshua Boger et al. profile →
Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of α‐ and β‐cyclodextrins

1978 234 citations Joshua Boger et al. profile →

Peers

Countries citing papers authored by Joshua Boger

Since Specialization

Citations

This map shows the geographic impact of Joshua Boger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Boger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Boger more than expected).

Fields of papers citing papers by Joshua Boger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Boger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Boger. The network helps show where Joshua Boger may publish in the future.

Co-authorship network of co-authors of Joshua Boger

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Boger. A scholar is included among the top collaborators of Joshua Boger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Boger. Joshua Boger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular and biochemical characterization of VX-710 as a chemosensitizer 1997 ·Anti-Cancer Drugs ·Ursula A. Germann, (unknown), Valerie S. Mason, Robert E. Zelle, John P. Duffy, Vincent Galullo, David M. Armistead, Jeffrey O. Saunders, Joshua Boger, Matthew W. Harding	119
2	Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin 1995 ·Acta Crystallographica Section D Biological Crystallography ·Keith P. Wilson, Masayuki Yamashita, Michael D. Sintchak, (unknown), Mark A. Murcko, Joshua Boger, John A. Thomson, Matthew J. Fitzgibbon, Jane R. Black, Manuel A. Navia	100
3	Structures of complexes of rhizopuspepsin with pepstatin and other statine‐containing inhibitors 1992 ·Proteins Structure Function and Bioinformatics ·K. Suguna, Eduardo A. Padlan, R. Bott, Joshua Boger, Kevin Parris, David R. Davies	29
4	Controlling the stereochemistry of the ring junction in hexahydrodibenzofurans 1991 ·The Journal of Organic Chemistry ·Kathleen M. Rupprecht, Joshua Boger, Karst Hoogsteen, Robert B. Nachbar, James P. Springer	29
5	The selectivity of statine-based inhibitors against various human aspartic proteinases 1990 ·Biochemical Journal ·R A Jupp, Ben M. Dunn, J Jacobs, G P Vlasuk, Karen E. Arcuri, Daniel F. Veber, Debra S. Perlow, Linda S. Payne, Joshua Boger, (unknown), (unknown), J. ten Broeke, David Hangauer, (unknown), William J. Greenlee, John Kay	34
6	2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis 1989 ·Journal of Medicinal Chemistry ·Milton L. Hammond, Ihor E. Kopka, Robert A. Zambias, Charles G. Caldwell, Joshua Boger, (unknown), (unknown), Silvi Luell, D. Euan MacIntyre	31
7	X-ray studies of aspartic proteinase-statine inhibitor complexes 1989 ·Biochemistry ·J.B. Cooper, S. I. Foundling, T.L. Blundell, Joshua Boger, R A Jupp, John Kay	47
8	A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. 1988 ·PubMed ·(unknown), Joshua Boger, Francis J. Dumont, Raymond A. Firestone, (unknown), (unknown), (unknown), (unknown), (unknown), Judith M. Pisano	24
9	Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency 1988 ·Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, B. Evans, Roger Freidinger, Kenneth E. Rittle, Linda S. Payne, Joshua Boger, Willie L. Whitter, Bruce I. LaMont	30
10	Site-Specific Cleavage of a Fusion Protein by Renin 1987 ·DNA ·M L Haffey, (unknown), Joshua Boger	6
11	Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini 1987 ·Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, B. Evans, Kenneth E. Rittle, Joshua Boger, Martin Poe, Bruce I. LaMont, Robert J. Lynch, E H Ulm	9
12	Clinical goal in sight for small molecule renin inhibitors 1987 ·Trends in Pharmacological Sciences ·Joshua Boger	11
13	Antibodies of predetermined specificity to the major charged species of human interleukin 1. 1986 ·Proceedings of the National Academy of Sciences ·G Limjuco, Stefan Galuska, Jayne Chin, Patricia M. Cameron, Joshua Boger, John A. Schmidt	28
14	Synthesis of α-ω-Diamino Acids: An Efficient Preparation of DL-Homolysine and Protected Derivatives 1985 ·Synthetic Communications ·Linda S. Payne, Joshua Boger	12
15	Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statine 1985 ·Journal of Medicinal Chemistry ·Joshua Boger, Linda S. Payne, Debra S. Perlow, (unknown), Martin Poe, Edward H. Blaine, E H Ulm, Terry W. Schorn, Bruce I. LaMont	111
16	Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs. 1984 ·Hypertension ·Edward H. Blaine, Terry W. Schorn, Joshua Boger	57
17	Preliminary X-ray crystallographic data on mouse submaxillary gland renin and renin-inhibitor complexes. 1984 ·Journal of Biological Chemistry ·Manuel A. Navia, James P. Springer, Martin Poe, Joshua Boger, Karst Hoogsteen	17
18	Renin inhibitors containing 2-substituted statine 1984 ·Biochemical Society Transactions ·Daniel F. Veber, Mark G. Bock, Stephen F. Brady, E H Ulm, David W. Cochran, Graham Smith, Bruce I. LaMont, Robert M. DiPardo, Martin Poe, Roger Freidinger, B. Evans, Joshua Boger	7
19	Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: a host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution 1979 ·Journal of the American Chemical Society ·Joshua Boger, Jeremy R. Knowles	34
20	Catalysis in dipolar aprotic solvents. Proton-relay mechanism resembling the mechanism of action of serine enzyme 1971 ·Journal of the American Chemical Society ·Paul Haake, (unknown), Joshua Boger	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact